HME and DME companies with strong recurring rental revenue and clean Medicare compliance typically trade between 3.5x and 5.5x EBITDA in today's lower middle market.
Home medical equipment businesses are valued primarily on EBITDA, with multiples heavily influenced by recurring rental revenue quality, Medicare/Medicaid compliance history, payor diversification, and accreditation status. Lower middle market HME companies generating $1M–$5M in revenue typically trade between 3.5x and 5.5x EBITDA. Businesses with diversified referral networks, clean billing compliance, and high rental-to-sales ratios command premiums, while those facing Medicare audits or payor concentration face meaningful valuation discounts.
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed or High-Risk | $150K–$400K | 2.5x–3.4x | Open Medicare audits, lapsed accreditation, heavy payor concentration, aging equipment fleet, or owner-dependent operations with no management layer. |
| Average / Market Rate | $300K–$600K | 3.5x–4.4x | Stable Medicare/Medicaid revenues, current ACHC accreditation, moderate rental mix, and some referral relationships but limited documentation or management depth. |
| Above Average | $500K–$900K | 4.5x–5.0x | Strong recurring rental base exceeding 60% of revenue, diversified payor mix, documented referral relationships, trained staff, and clean compliance history. |
| Premium / Strategic | $700K+ | 5.0x–5.5x | Multi-location operator with scalable billing infrastructure, commercial insurance contracts, proprietary hospital referral relationships, and active roll-up acquisition interest. |
Recurring Rental Revenue Mix
High Positive impactBusinesses deriving 60%+ of revenue from long-term equipment rentals—oxygen, CPAP, power wheelchairs—command premium multiples due to predictable cash flow and lower customer churn.
Medicare/Medicaid Compliance History
High Positive or Negative impactClean billing records, no open OIG audits, and zero recoupment exposure are prerequisites for premium pricing. Unresolved compliance issues can eliminate financing options entirely.
Payor and Referral Diversification
Moderate Positive impactA balanced mix of Medicare, Medicaid, and commercial payors, combined with referrals from multiple hospitals and physician groups, reduces concentration risk and supports higher multiples.
Accreditation Status
Moderate Positive impactActive ACHC or Joint Commission accreditation in good standing signals operational quality and regulatory readiness, reducing buyer diligence risk and supporting lender confidence for SBA financing.
Owner Dependency and Management Depth
Moderate Negative impactBusinesses where the owner controls key referral relationships or billing operations without documented processes face valuation discounts and longer transitions post-close.
Private equity roll-up activity has intensified in the HME sector as aging demographics fuel demand for home oxygen, respiratory therapy, and mobility equipment. Strategic acquirers are paying 5.0x–5.5x EBITDA for businesses with strong referral networks and scalable billing platforms. SBA lenders remain active but scrutinize Medicare reimbursement risk closely. Competitive bidding program pressure continues to compress margins, reinforcing buyer preference for businesses with strong commercial insurance contract revenue to offset government reimbursement headwinds.
Single-location oxygen and respiratory therapy provider, Southeast U.S., ACHC-accredited, 65% rental revenue, clean Medicare billing history, owner transitioning after 18 months.
$420K
EBITDA
4.3x
Multiple
$1.81M
Price
Two-location HME operator, Midwest, diversified product mix including CPAP, mobility, and wound care, strong hospital referral relationships, documented billing systems, experienced office manager retained.
$680K
EBITDA
5.0x
Multiple
$3.40M
Price
Single-location DME provider, open Medicare audit at close, limited commercial payor contracts, aging rental fleet requiring reinvestment, owner-dependent referral base with no transition documentation.
$310K
EBITDA
3.2x
Multiple
$992K
Price
EBITDA Valuation Estimator
Get your Home Medical Equipment business value range instantly
Industry: Home Medical Equipment · Multiples based on 3.5x–4.4x (Average / Market Rate)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Most HME businesses in the $1M–$5M revenue range sell for 3.5x–5.5x EBITDA. Clean compliance history, strong rental revenue, and diversified referrals drive results toward the upper end.
Open audits, recoupment exposure, or heavy Medicare concentration reduce multiples significantly. Buyers and SBA lenders treat unresolved billing compliance issues as deal-killers or major price reduction triggers.
Yes. SBA 7(a) loans are commonly used for HME acquisitions. Lenders typically require 10–20% buyer equity, clean Medicare supplier enrollment, active accreditation, and a seller note for gap financing.
Recurring rental revenue quality is the single most important driver. High rental mix signals predictable cash flow, reduces buyer risk, and directly supports higher EBITDA multiples and better deal terms.
More Home Medical Equipment Guides
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers